The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's diseaseJoel Simrén, Nicholas J. Ashton, Antoine Leuzy et al.|Alzheimer s & Dementia|2021Cited by 354
Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's diseasePratishtha Chatterjee, Ralph N. Martins, Steve Pedrini et al.|Alzheimer s & Dementia|2021Cited by 238
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive changeDenis S. Smirnov, Douglas Galasko, Nicholas J. Ashton et al.|Acta Neuropathologica|2022Cited by 229
MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s diseaseSriram Balusu, Bart De Strooper, Katrien Horré et al.|Science|2023Cited by 216
Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 yearsJoel Simrén, Kaj Blennow, Ulf Andréasson et al.|Brain Communications|2022Cited by 187